Cargando…

Early development of broad neutralizing antibodies in HIV-1 infected infants

Eliciting protective neutralizing antibodies (NAbs) against HIV-1 is daunting because of the extensive genetic and antigenic diversity of HIV-1. Moreover, broad and potent responses are uncommon even during persistent infection, with only a subset of adults developing broadly neutralizing antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goo, Leslie, Chohan, Vrasha, Nduati, Ruth, Overbaugh, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060046/ https://www.ncbi.nlm.nih.gov/pubmed/24859529 http://dx.doi.org/10.1038/nm.3565

Ejemplares similares

Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk
por: Milligan, Caitlin, et al.
Publicado: (2016)

P04-53 LB. Potent and broad HIV-specific neutralizing antibodies in infants are not associated with prevention of mother to infant HIV transmission
por: Lynch, J, et al.
Publicado: (2009)

A diverse collection of B cells responded to HIV infection in infant BG505
por: Simonich, Cassandra, et al.
Publicado: (2021)

Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage
por: Simonich, Cassandra A., et al.
Publicado: (2019)

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
por: Yaffe, Zak A., et al.
Publicado: (2023)

Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection
por: Piantadosi, Anne, et al.
Publicado: (2007)

Functional development of a V3/glycan-specific broadly neutralizing antibody isolated from a case of HIV superinfection
por: Shipley, Mackenzie M, et al.
Publicado: (2021)

Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants
por: Naiman, Nicole E., et al.
Publicado: (2019)

The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection
por: Cortez, Valerie, et al.
Publicado: (2015)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

Mother–Infant HIV Transmission: Do Maternal HIV-Specific Antibodies Protect the Infant?
por: Overbaugh, Julie
Publicado: (2014)

Correlates of HIV detection among breastfeeding postpartum Kenyan women eligible under Option B+
por: Chan, Mary, et al.
Publicado: (2019)

HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)

HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads
por: Mabuka, Jennifer, et al.
Publicado: (2012)

Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection
por: Guenthoer, Jamie, et al.
Publicado: (2023)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
por: Ahmed, Yousuf, et al.
Publicado: (2017)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
por: Bruel, Timothée, et al.
Publicado: (2016)

The expanding array of HIV broadly neutralizing antibodies
por: McCoy, Laura E.
Publicado: (2018)

Broadly Neutralizing Antibodies for HIV-1 Prevention
por: Walsh, Stephen R., et al.
Publicado: (2021)

Broadly neutralizing monoclonal antibodies for HIV prevention
por: Miner, Maurine D., et al.
Publicado: (2021)

Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development
por: Wiehe, Kevin, et al.
Publicado: (2018)

Maternal Envelope gp41 Ectodomain-Specific Antibodies Are Associated With Increased Mother-to-Child Transmission of Human Immunodeficiency Virus-1
por: Naiman, Nicole E, et al.
Publicado: (2020)

Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection
por: Mishra, Nitesh, et al.
Publicado: (2020)

Broadly neutralizing antibodies and vaccine design against HIV-1 infection
por: Wang, Qian, et al.
Publicado: (2019)

HIV-1 Superinfection in Women Broadens and Strengthens the Neutralizing Antibody Response
por: Cortez, Valerie, et al.
Publicado: (2012)

bNAber: database of broadly neutralizing HIV antibodies
por: Eroshkin, Alexey M., et al.
Publicado: (2014)

Identification and specificity of broadly neutralizing antibodies against HIV
por: McCoy, Laura E., et al.
Publicado: (2017)

P04-15. Prevalence of broadly neutralizing antibody responses during acute/early HIV infection
por: Mikell, I, et al.
Publicado: (2009)

Immunologic characteristics of HIV‐infected individuals who make broadly neutralizing antibodies
por: Borrow, Persephone, et al.
Publicado: (2017)

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
por: Prigent, Julie, et al.
Publicado: (2018)

Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings
por: Dugdale, Caitlin M., et al.
Publicado: (2023)

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01
por: Pinto, Dora, et al.
Publicado: (2019)

HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and are Commonly Detected in Plasma from HIV-infected Humans
por: Williams, Katherine L., et al.
Publicado: (2015)

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
por: Schoofs, Till, et al.
Publicado: (2019)

Designer antigens for elicitation of broadly neutralizing antibodies against HIV
por: Kok, Tuckweng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tbdj4drt3uene0sdskvhkjrsni